- Home
- CELC vs FISI Comparison
CELC vs FISI Comparison
Compare CELC & FISI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- FISI
- Stock Information
- Founded
- CELC 2011
- FISI 1817
- Country
- CELC United States
- FISI United States
- Employees
- CELC N/A
- FISI N/A
- Industry
- CELC Medical Specialities
- FISI Major Banks
- Sector
- CELC Health Care
- FISI Finance
- Exchange
- CELC Nasdaq
- FISI Nasdaq
- Market Cap
- CELC 440.0M
- FISI 522.5M
- IPO Year
- CELC 2017
- FISI 1999
- Fundamental
- Price
- CELC $13.04
- FISI $26.93
- Analyst Decision
- CELC Strong Buy
- FISI Buy
- Analyst Count
- CELC 6
- FISI 3
- Target Price
- CELC $30.67
- FISI $33.00
- AVG Volume (30 Days)
- CELC 196.9K
- FISI 166.8K
- Earning Date
- CELC 08-13-2025
- FISI 07-24-2025
- Dividend Yield
- CELC N/A
- FISI 4.69%
- EPS Growth
- CELC N/A
- FISI N/A
- EPS
- CELC N/A
- FISI N/A
- Revenue
- CELC N/A
- FISI $108,628,000.00
- Revenue This Year
- CELC N/A
- FISI $101.16
- Revenue Next Year
- CELC N/A
- FISI $6.68
- P/E Ratio
- CELC N/A
- FISI N/A
- Revenue Growth
- CELC N/A
- FISI N/A
- 52 Week Low
- CELC $7.58
- FISI $18.56
- 52 Week High
- CELC $19.77
- FISI $29.79
- Technical
- Relative Strength Index (RSI)
- CELC 60.10
- FISI 62.81
- Support Level
- CELC $12.48
- FISI $25.60
- Resistance Level
- CELC $13.60
- FISI $26.16
- Average True Range (ATR)
- CELC 0.74
- FISI 0.58
- MACD
- CELC 0.04
- FISI 0.17
- Stochastic Oscillator
- CELC 75.91
- FISI 95.45
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About FISI Financial Institutions Inc.
Financial Institutions Inc operates as a financial holding company, engages in the provision of a wide range of consumer and commercial banking services to individuals, municipalities, and businesses in Western and Central New York. It operates through one segment: The Banking segment which includes all of the company's retail and commercial banking operations.